Testing for COVID-19: what you need to know
Drug Misuse in America 2019: Physician Perspectives and Diagnostic Insights on the Evolving Drug Crisis
Read more here
Find out why our new PrEP Panel offering is a game changer!
Watch our video podcast here
Laboratory Blood-Based Testing for Lyme Disease at a National Reference Laboratory (2010-2016)
Read more here.
Assessment of plasma β-Amyloid 1-42/1-40 ratio may help identify patients with Alzheimer’s Disease
Click here to learn more
Non-invasive prenatal cell-free DNA screening
A recent study indicates high specificity and sensitiivity not only for women at high-risk, but also for women at average risk.
Screening for Sexually Transmitted Infections
Learn more by watching our short educational vignette here
During this presentation you will learn about the background and epidemiology of COVID-19, and the clinical progression of the disease. Dr Wohlgemuth provides an overview... Read more ▸
Dr Gulati discusses sex differences in cardiovascular health and outcomes, explains the cardiovascular symptoms and differences in care for men and women and helps the... Read more ▸
Expert InsightsView All Expert Insights ▸
PublicationsView All Publications ▸
Role of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in the Diagnosis and Management of Mediastinal Cyst.
J Bronchology Interv Pulmonol. 2020 Apr:142-146. doi: 10.1097/LBR.0000000000000640.
Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.
Am J Surg Pathol. 2020 Apr. doi: 10.1097/PAS.0000000000001494. [Epub ahead of print]
Pathologe. 2020 Apr doi: 10.1007/s00292-020-00787-8. [Epub ahead of print]
Bilateral pulmonary metastases of papillary thyroid carcinoma in a 12-year-old child-A case report and review of the literature.
Radiol Case Rep. 2020 Apr;15:799-802. doi: 10.1016/j.radcr.2020.03.022. eCollection 2020 Jun.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.
J Pathol. 2020 Apr;250:667-684. doi: 10.1002/path.5406. Epub 2020 Apr 9.
Reply to 'Comment on "Histopathologic features distinguishing secondary syphilis from its mimickers".
J Am Acad Dermatol. 2020 Apr. pii: S0190-9622(20)30531-4. doi: 10.1016/j.jaad.2020.03.106. [Epub ahead of print]